Fundz

Kashiv BioSciences

New Jersey, United States · Biotechnology, Health Care, Manufacturing · 487 employees

Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.

Funding history

  • Funding Round — $6.5B — Dec 2025

Recent signals

  • Apr 14, 2026: Kashiv BioSciences Appoints Viet Nguyen as Chief Operating Officer
  • Dec 23, 2025: Raised $6.5B
  • Nov 01, 2024: Dr. Sandeep Nilkanth Athalye Appointed as Global Chief Executive Officer at Kashiv BioSciences, LLC
  • Jul 01, 2024: Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)

See plans & pricing → Track Kashiv BioSciences’s funding, hiring, and signals — with verified contacts — on Fundz.